FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2509882972> ?p ?o ?g. }

• W2509882972 endingPage "197.e3" @default.
• W2509882972 startingPage "189" @default.
• W2509882972 abstract "Introduction Preclinical studies suggest that angiotensin system inhibitors (ASI) and bevacizumab improve tumor perfusion and chemotherapy efficacy. We performed a retrospective study to examine whether concomitant ASI use during carboplatin and paclitaxel (CP) without or with bevacizumab (CPB) was associated with improved overall survival (OS) in patients with advanced nonsquamous, non–small-cell lung cancer (NS-NSCLC). Patients and Methods In a retrospective cohort study, adult patients diagnosed with stage IIIB or IV NS-NSCLC between 2005 and 2011 were identified from tumor registries at 1 of 4 Kaiser Permanente regions. Survival differences between those who did and did not receive ASIs concomitant with chemotherapy (CP or CPB) were assessed using propensity score–matched proportional hazard models. OS was measured from the initiation of chemotherapy until death, disenrollment, or December 31, 2012. Results Of the 1465 CP and 348 CPB patients included, 273 (19%) and 78 (22%), respectively, received concomitant ASI. For CP patients with and without concomitant ASI exposure, median OS was 12.0 and 8.4 months, respectively (crude hazard ratio [HR], 0.72; 95% confidence interval [CI], 0.63-0.84). For CPB patients, the comparable median OS was 14.9 and 11.9 months, respectively (crude HR, 0.77; 95% CI, 0.57-1.02). Using propensity score–matched cohorts, the HR for concomitant ASI use was 0.73 (95% CI, 0.61-0.88) for CP patients and 0.79 (95% CI, 0.51-1.21) for CPB patients. Conclusion Concomitant ASI receipt during CP or CPB therapy for NS-NSCLC was associated with improved survival, although the association was only statistically significant in the CP group." @default.
• W2509882972 created "2016-09-16" @default.
• W2509882972 creator A5004977265 @default.
• W2509882972 creator A5015585176 @default.
• W2509882972 creator A5031698839 @default.
• W2509882972 creator A5044169622 @default.
• W2509882972 creator A5044332098 @default.
• W2509882972 creator A5045288286 @default.
• W2509882972 creator A5078947127 @default.
• W2509882972 creator A5087901835 @default.
• W2509882972 creator A5090249589 @default.
• W2509882972 date "2017-03-01" @default.
• W2509882972 modified "2023-10-13" @default.
• W2509882972 title "Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer" @default.
• W2509882972 cites W1984262040 @default.
• W2509882972 cites W1992146834 @default.
• W2509882972 cites W1995580600 @default.
• W2509882972 cites W1998266575 @default.
• W2509882972 cites W2009187570 @default.
• W2509882972 cites W2018717854 @default.
• W2509882972 cites W2020452028 @default.
• W2509882972 cites W2022540958 @default.
• W2509882972 cites W2029607498 @default.
• W2509882972 cites W2029882754 @default.
• W2509882972 cites W2036193982 @default.
• W2509882972 cites W2060287969 @default.
• W2509882972 cites W2079142824 @default.
• W2509882972 cites W2079311356 @default.
• W2509882972 cites W2089927136 @default.
• W2509882972 cites W2091446228 @default.
• W2509882972 cites W2098523116 @default.
• W2509882972 cites W2102520493 @default.
• W2509882972 cites W2104616343 @default.
• W2509882972 cites W2119868026 @default.
• W2509882972 cites W2121690051 @default.
• W2509882972 cites W2122532950 @default.
• W2509882972 cites W2125603252 @default.
• W2509882972 cites W2126049444 @default.
• W2509882972 cites W2126310082 @default.
• W2509882972 cites W2137816700 @default.
• W2509882972 cites W2144168223 @default.
• W2509882972 cites W2145835533 @default.
• W2509882972 cites W2147275279 @default.
• W2509882972 cites W2151151767 @default.
• W2509882972 cites W2158303916 @default.
• W2509882972 cites W2166889936 @default.
• W2509882972 cites W2273029502 @default.
• W2509882972 cites W2332037317 @default.
• W2509882972 cites W2337980776 @default.
• W2509882972 cites W2530522266 @default.
• W2509882972 cites W2626223149 @default.
• W2509882972 cites W4245958676 @default.
• W2509882972 doi "https://doi.org/10.1016/j.cllc.2016.07.008" @default.
• W2509882972 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5424707" @default.
• W2509882972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27637408" @default.
• W2509882972 hasPublicationYear "2017" @default.
• W2509882972 type Work @default.
• W2509882972 sameAs 2509882972 @default.
• W2509882972 citedByCount "24" @default.
• W2509882972 countsByYear W25098829722017 @default.
• W2509882972 countsByYear W25098829722018 @default.
• W2509882972 countsByYear W25098829722019 @default.
• W2509882972 countsByYear W25098829722020 @default.
• W2509882972 countsByYear W25098829722021 @default.
• W2509882972 countsByYear W25098829722022 @default.
• W2509882972 countsByYear W25098829722023 @default.
• W2509882972 crossrefType "journal-article" @default.
• W2509882972 hasAuthorship W2509882972A5004977265 @default.
• W2509882972 hasAuthorship W2509882972A5015585176 @default.
• W2509882972 hasAuthorship W2509882972A5031698839 @default.
• W2509882972 hasAuthorship W2509882972A5044169622 @default.
• W2509882972 hasAuthorship W2509882972A5044332098 @default.
• W2509882972 hasAuthorship W2509882972A5045288286 @default.
• W2509882972 hasAuthorship W2509882972A5078947127 @default.
• W2509882972 hasAuthorship W2509882972A5087901835 @default.
• W2509882972 hasAuthorship W2509882972A5090249589 @default.
• W2509882972 hasBestOaLocation W25098829722 @default.
• W2509882972 hasConcept C126322002 @default.
• W2509882972 hasConcept C126894567 @default.
• W2509882972 hasConcept C141071460 @default.
• W2509882972 hasConcept C143998085 @default.
• W2509882972 hasConcept C167135981 @default.
• W2509882972 hasConcept C17923572 @default.
• W2509882972 hasConcept C207103383 @default.
• W2509882972 hasConcept C2776256026 @default.
• W2509882972 hasConcept C2776694085 @default.
• W2509882972 hasConcept C2777802072 @default.
• W2509882972 hasConcept C2778239845 @default.
• W2509882972 hasConcept C2779384505 @default.
• W2509882972 hasConcept C2781451048 @default.
• W2509882972 hasConcept C44249647 @default.
• W2509882972 hasConcept C71924100 @default.
• W2509882972 hasConceptScore W2509882972C126322002 @default.
• W2509882972 hasConceptScore W2509882972C126894567 @default.
• W2509882972 hasConceptScore W2509882972C141071460 @default.
• W2509882972 hasConceptScore W2509882972C143998085 @default.
• W2509882972 hasConceptScore W2509882972C167135981 @default.
• W2509882972 hasConceptScore W2509882972C17923572 @default.

• next